Lumboperitonial shunt infection due to Chryseobacterium indologenes

Pediatric Infectious Disease Journal

Volumn 26, Issue 7, 2007, Pages 657-659

  Al Tatari, Hossam ^a   Asmar, Basim I ^a   Ang, Jocelyn Y ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Central nervous system; Chryseobacterium indologenes; Infection; Lumboperitonial shunt

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

ADD ON THERAPY; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; CASE REPORT; CEREBROSPINAL FLUID; CHRYSEOBACTERIUM INDOLOGENES; DRUG WITHDRAWAL; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID SHUNTS; CHRYSEOBACTERIUM; FLAVOBACTERIACEAE INFECTIONS; HUMANS; MALE;

EID: 34347333549     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3180616d25     Document Type: Article

References (14)

1. Murray PR, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press;1995:528-530.
2. Koneman EW, Allen SD, Sommers HM, Dowell VR, Winn, WC. Colour Atlas and Text Book of Diagnostic Microbiology. 3rd ed. Philadelphia: Lippincott; 1988:161.
3. Mandell GL, Dolin R. Principles and Practice of Infective Disease. 6th ed. 2005;2:2757-2759.
4. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect. 2001;7:391-393.
5. Hsueh PR, Hsiue TR, Wu JJ, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis. 1996;23:550-555.
6. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis. 1997;16:568-574.
7. Lin JT, Wang WS, Yen CC, et al. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand J Infect Dis. 2003;35:882-883.
8. Lu PC, Chan JC. Flavobacterium indologenes keratitis. Ophthalmologica. 1997;211:98-100.
9. Kienzle N, Muller M, Pegg S. Chryseobacterium in burn wounds. Burns. 2001;27:179-182.
10. Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol. 2005;43:2021-2023.
11. Green BT, Nolan PE. Cellulitis and bacteraemia due to Chryseobacterium indologenes. J Infect. 2001;42:219-220.
12. Doiz O, Llorente MT, Mateo A, Seral C, Garcia C, Rubio MC. Corneal abscess by Flavobacterium indologenes. A case report-. Enferm Infecc Microbiol Clin. 1999;17:149-150.
13. Marcos Sanchez F, Plaza Diaz R, Juarez Ucelay F, Duran Perez-Navarro A. Pneumonia from Flavobacterium indologenes (group II B) in an immunodepressed patient-. An Med Interna. 1993;10:312.
14. Aber RC, Wennersten C, Moellering RC Jr. Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother. 1978;14:483-487.